NCT04343014

Brief Summary

Patients admit to the operation rooms of First Affiliated Hospital of Nanjing Medical University and requiring endotracheal intubation for general anesthesia will be enrolled in this case controlled study. Patients 1) aged 18 to 70 years; 2) ASA graded I\~II class; 3) general anesthesia should be performed under endotracheal intubation, will be included from this study. Patients 1) with organ transplant operations; 2) with thoracic and cardiac vascular surgery; 3) with severe heart or lung disease; 4) BMI over 35kg/m2, will be excluded from this study. The primary aim is to compare airway clearance for fibreoptic tracheal intubation in each patient position. Secondary outcomes include times to view the vocal cord and carina, the time for tube advancement through the vocal cords, as well as the total time to achieve tracheal intubation.Two anesthesiologists with 5 years of experience in conventional endotracheal intubation and trained for fibreoptic intubation will perform the maneuvers.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
300

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2016

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 10, 2016

Completed
1.6 years until next milestone

First Submitted

Initial submission to the registry

October 8, 2017

Completed
2.5 years until next milestone

First Posted

Study publicly available on registry

April 13, 2020

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2020

Completed
9 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 10, 2020

Completed
Last Updated

February 10, 2021

Status Verified

February 1, 2021

Enrollment Period

4.7 years

First QC Date

October 8, 2017

Last Update Submit

February 7, 2021

Conditions

Keywords

fibreoptic intubation

Outcome Measures

Primary Outcomes (1)

  • Feasibility of intubation.

    Successs of intubation at different attempts.

    From start of intubation to successfully intubated (the endotracheal tube enters the trachea and the cuff is inflated), usually within 3 minutes.

Secondary Outcomes (4)

  • Epiglottis level

    within 30 seconds after the beginning of fibroscopy

  • Carina time

    within 90 seconds

  • Successful Intubation on 1st Attemp

    from start of first intubation to end of first intubation attempt

  • Number of attempts for tube advancement

    within 120 seconds

Study Arms (2)

Tongue Root Retractor

EXPERIMENTAL

Patients in this arm will receive fibroscopic endotracheal intubation with tongue root retractors.

Device: Tongue Root Retractor

Conventional Fibroscope

ACTIVE COMPARATOR

Patients in this arm will receive fibroscopic endotracheal intubation without any other devices.

Device: Conventional Fibroscope

Interventions

Fibroptic endutracheal intubation will be performed with tongue root retractor.

Tongue Root Retractor

Fibroptic endutracheal intubation will be performed in conventional way.

Conventional Fibroscope

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • aged 18 to 70 years
  • ASA graded I\~II class
  • scheduled for elective surgery requiring orotracheal intubation

You may not qualify if:

  • with organ transplant operations
  • with thoracic and cardiac vascular surgery
  • with severe cadiac or pulmonary disease
  • BMI over 35kg/m2

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The First Affiliated Hospital of Nanjing Medical University

Nanjing, Jiangsu, 210029, China

Location

Study Officials

  • Zhengnian Ding, M.D.

    The First Affiliated Hospital with Nanjing Medical University

    STUDY CHAIR
  • Xiaofei Cao, M.D.

    The First Affiliated Hospital with Nanjing Medical University

    PRINCIPAL INVESTIGATOR
  • Junbei Wu, M.D.

    The First Affiliated Hospital with Nanjing Medical University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 8, 2017

First Posted

April 13, 2020

Study Start

March 10, 2016

Primary Completion

December 1, 2020

Study Completion

December 10, 2020

Last Updated

February 10, 2021

Record last verified: 2021-02

Locations